The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.

Simsek, Cihan

The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries. [electronic resource] - JACC. Cardiovascular interventions Oct 2010 - 1051-8 p. digital

Publication Type: Comparative Study; Journal Article

1876-7605

10.1016/j.jcin.2010.08.003 doi


Aged
Angioplasty, Balloon, Coronary--adverse effects
Cardiovascular Agents--administration & dosage
Chi-Square Distribution
Coronary Artery Disease--mortality
Drug-Eluting Stents
Female
Humans
Kaplan-Meier Estimate
Male
Metals
Middle Aged
Myocardial Infarction--etiology
Netherlands
Paclitaxel--administration & dosage
Proportional Hazards Models
Prosthesis Design
Registries
Risk Assessment
Risk Factors
Sirolimus--administration & dosage
Stents
Thrombosis--etiology
Time Factors
Treatment Outcome